August 26, 2016 1:02 AM ET


Company Overview of Okairos AG

Company Overview

Okairos AG, a clinical-stage biopharmaceutical company, engages in the discovery, development, and commercialization of T-cell based vaccines for infectious diseases and cancer. It focuses on developing genetic vaccines for hepatitis C virus, malaria, HIV, respiratory syncytial virus, Ebola and Marburg, tuberculosis, and influenza, as well as cancer. The company was founded in 2007 and is headquartered in Basel, Switzerland. It has laboratories in Rome and Naples, Italy. As of May 29, 2013, Okairos AG operates as a subsidiary of GlaxoSmithKline plc.

Aeschenvorstadt 71

Basel,  4051


Founded in 2007


41 61 270 35 35


41 61 270 35 00

Key Executives for Okairos AG

Co-Founder, Chief Executive Officer, Managing Director and Director
Co-Founder and Chief Scientific Officer
Co-Founder and Senior Director of Vector Development
Co-Founder and Director of Immunology
Clinical Director
Compensation as of Fiscal Year 2016.

Similar Private Companies By Industry

Company Name Region
AB2 Bio Ltd. Europe
AC Immune SA Europe
ADC Therapeutics SA Europe
AlloCyte Pharmaceuticals AG Europe
Amal Therapeutics SA Europe

Recent Private Companies Transactions

No transactions available in the past 12 months.

The information and data displayed in this profile are created and managed by Capital IQ, a Standard & Poor's company. does not create or control the content. For inquiries, please contact Capital IQ directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
NYC2012, Inc. United States
Bertelsmann AG Europe
Rush University United States
Bloomberg L.P. United States

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Okairos AG, please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at